trans‐ferulic acid attenuates hyperglycemia‐induced oxidative stress and modulates glucose metabolism by activating AMPK signaling pathway in vitro
- 3 January 2022
- journal article
- research article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (2) , e14038
Abstract
Adenosine monophosphate-activated protein kinase (AMPK) is a potent metabolic regulator and an attractive target for antidiabetic activators. Here we report for the first that, trans-ferulic acid (TFA) is a potent dietary bioactive molecule of hydroxycinnamic acid derivative for the activation of AMPK with a maximum increase in phosphorylation (2.71/2.67 ± 0.10; p < .001 vs. high glucose [HG] control) in hyperglycemia-induced human liver cells (HepG2) and rat skeletal muscle cells (L6), where HG suppresses the AMPK pathway. It was also observed that TFA increased activation of AMPK in a dose- and time-dependent manner and also increased the phosphorylation of acetyl-CoA carboxylase (ACC), suggesting that it may promotes fatty acid oxidation; however, pretreatment with compound C reversed the effect. In addition, TFA reduced the level of intracellular reactive oxygen species (ROS) and nitric oxide (NO) induced by hyperglycemia and subsequently increased the level of glutathione. Interestingly, TFA also upregulated the glucose transporters, GLUT2 and GLUT4, and inhibited c-Jun N-terminal protein kinase (JNK1/2) by decreasing the phosphorylation level in tested cells under HG condition. Our studies provide critical insights into the mechanism of action of TFA as a potential natural activator of AMPK under hyperglycemia. Practical applications Hydroxycinnamic acid derivatives possess various pharmacological properties and are found to be one of the most ubiquitous groups of plant metabolites in almost all dietary sources. However, the tissue-specific role and its mechanism under hyperglycemic condition remain largely unknown. The present study showed that TFA is a potent activator of AMPK under HG condition and it could be used as a therapeutic agent against hyperglycemia in type 2 diabetes.Keywords
This publication has 65 references indexed in Scilit:
- Alteration of JNK-1 Signaling in Skeletal Muscle Fails to Affect Glucose Homeostasis and Obesity-Associated Insulin Resistance in MicePLOS ONE, 2013
- Cellular Dysfunction in Diabetes as Maladaptive Response to Mitochondrial Oxidative StressExperimental Diabetes Research, 2012
- A pharmacological appraisal of medicinal plants with antidiabetic potentialJournal of Pharmacy and Bioallied Sciences, 2012
- Interaction of Cinnamic Acid Derivatives with Commercial Hypoglycemic Drugs on 2-Deoxyglucose Uptake in 3T3-L1 AdipocytesJournal of Agricultural and Food Chemistry, 2011
- Risk of Bladder Cancer Among Diabetic Patients Treated With PioglitazoneDiabetes Care, 2011
- Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical ConsiderationsThe Review of Diabetic Studies, 2009
- Ferulic Acid: Therapeutic Potential Through Its Antioxidant PropertyJournal of Clinical Biochemistry and Nutrition, 2007
- Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substratesProceedings of the National Academy of Sciences, 2006
- Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistanceProceedings of the National Academy of Sciences, 2006
- Ferulic acid alleviates lipid peroxidation in diabetic ratsPhytotherapy Research, 2004